Breast cancer staging: neoadjuvant chemotherapy benefits
relapsed/refractory multiple myeloma bi-specific antibody: big benefits
Audio Journal of Oncology Podcast Erika Hamilton MD; 2025 SABCS: Small Molecule HER2 Inhibitor Tucatinib Improves Progression Free Survival...
Audio Journal of Oncology Podcast Wojciech Jurczak MD PhD; ASH 2025: Big Study Suggests Non-Covalent BTK Inhibitor Pirtobrutinib Could be...
Improved Responses to Anti-PD-1 immune therapy and chemotherapy could result from neoadjuvant radiation therapy for invasive luminal breast...
Audio Journal of Oncology Podcast Lorenzo Falchi MD; ASH 2025: Bispecific Antibody Epcoritamab Combination Beats Standard of Care for...
Audio Journal of Oncology Podcast Christian F. Singer MD; 2025 SABCS: Denosumab Bone Protection in ER-Positive Early Breast Cancer Brings...
Gentler therapy for AML in young fit patients had better outcomes compared to standard induction chemotherapy
Non-Covalent BTK Inhibitor First in CLL: Less Toxic, As Effective as Covalent
Healthy eating could be a key to breast cancer treatment success: microbiome influence in immunotherapy outcomes identified,
Audio Journal of Oncology Podcast Meletios Dimopoulos; ASH 2025: B-Cell Maturation Antigen Bispecific Antibody Linvoseltamab Brings High...
The donor pool for allogeneic stem cell transplantation could be greatly increased, improving access to transplant for minorities who are...